1Chen Z M,J iang LX,Chen YP,et aI.Addition of clopidogrel to as p irin in 45 852patients with acute myocardial infarcti on:randomised p lacebo2 contr oiled trial[J].Lancet,2005,366(9497):1607- 1621.
2Aronow W S.Drug treatment of peripheral arterial disease in the elderly[J].Drugs Aging,2006,23(1): 1 - 12.
3Lugnier C.Cyclic nucleo ti de phosphod iesterase(PDE) superfam il y:a new target for the development o f specific therapeutic agents[J].Phar m aco 1Ther,2006,109(3):366-398.
4ReillyM P,Mohler E R.Cil ostazol:treatment of intermittent claudicati on[J].Ann Phar macother,2001,35(1):48-56.
5Kariyazono H,Nakamura K,Shinkawa T,et al.Inhibiti on of plate- let aggregation and the release of selectin from platelets by cilostazol[J].Thromb Res,2001,101 (6):445 - 453.
6IKoda Y,K i kuch iM,Murakam iH,et al.Comparison of t he i nhibi tory effects o f cilostazo,l ace tylsa 1 icylicac i d and tic 1 opidi ne on platelet f unct ions ex v i vo.Random ized,doubleblind cross- over study[J].Arznei m it tel Forschung(Drug Research),1987,37 (5):563-- 566.
7陈灏珠.内科学[M] 第4版[M].北京:人民卫生出版社,1998.616.
8Dawson DL,Cutler BS,Meissner MH,et al.Cilostazol has beneficial effects in treatment of intermittent claudication:resuls from a multicenter,randomized,prospective,double blind trial[J]. Circulation, 1998(7):678.
5Regensteiner J, Ware J J, McCarthy W, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials [J]. J Am Geriatr Soc, 2002, 50:1939- 1946.
6Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication[J]. AmJ Med,2000, 109:523-530.
7[1]Kwaan HC,Colwell JA,Cruz S. Increased platelet aggregation in diabetes mellitus [J].J Lab Clin Med,1972,80:236
8[2]Dallinger KJ, Jenning PE, Toop MJ. Platelet aggregation and coagulation factors in insulin dependent diabetes with and without microangiopathy [J]. Diabetes Med,1987,4:44
9[3]Vague P, Juhan I. Red cell deformability, platelet aggregation,and insulin action [J]. Diabetes,1983,32(suppl 2):88
10[4]Yamazaki Y, Kawamura K, Yasuda H.Inhibitory effects of cilostazol on carotid hypertrophy in DM patients[J]. Yakuri to Chiryo,1994,21(11):4415
4HIATT WR, MONEY SR, BRASS EP. Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (CilostazoI: A Study in Long-term Effects) [J]. J Vasc Surg, 2008, 47(2): 330--336.
